Werewolf Therapeutics (HOWL ... with favorable tolerability profile and encouraging efficacy signals - - Additional preclinical data demonstrate INDUKINETM molecules’ anti-tumor potency with ...

Blood Moon Rise will bring back the director of the MCU Halloween special for an even more monstrous comic story ...

WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the ...

Werewolf is approaching critical inflection ... and the anticipated safety profile of product candidates constitute forward-looking statements within the meaning of The Private Securities ...